A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability

被引:168
|
作者
Hurov, Kristen E.
Cotta-Ramusino, Cecilia
Elledge, Stephen J. [1 ]
机构
[1] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
TTI1; TEL2; TTI2; PIKK; TTT complex; IR sensitivity; TELOMERE LENGTH REGULATION; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; LIFE-SPAN; CHECKPOINT; REGULATOR; PATHWAYS; TEL2P; PARTICIPATE;
D O I
10.1101/gad.1934210
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In response to DNA damage, cells activate a complex signal transduction network called the DNA damage response (DDR). To enhance our current understanding of the DDR network, we performed a genome-wide RNAi screen to identify genes required for resistance to ionizing radiation (IR). Along with a number of known DDR genes, we discovered a large set of novel genes whose depletion leads to cellular sensitivity to IR. Here we describe TTI1 (Tel two-interacting protein 1) and TTI2 as highly conserved regulators of the DDR in mammals. TTI1 and TTI2 protect cells from spontaneous DNA damage, and are required for the establishment of the intra-S and G2/M checkpoints. TTI1 and TTI2 exist in multiple complexes, including a 2-MDa complex with TEL2 (telomere maintenance 2), called the Triple T complex, and phosphoinositide-3-kinase-related protein kinases (PIKKs) such as ataxia telangiectasia-mutated (ATM). The components of the TTT complex are mutually dependent on each other, and act as critical regulators of PIKK abundance and checkpoint signaling.
引用
收藏
页码:1939 / 1950
页数:12
相关论文
共 33 条
  • [1] A DNA Damage Response Screen Identifies RHINO, a 9-1-1 and TopBP1 Interacting Protein Required for ATR Signaling
    Cotta-Ramusino, Cecilia
    McDonald, E. Robert, III
    Hurov, Kristen
    Sowa, Mathew E.
    Harper, J. Wade
    Elledge, Stephen J.
    SCIENCE, 2011, 332 (6035) : 1313 - 1317
  • [2] Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR
    Fangfang Wang
    Sora Jin
    Franklin Mayca Pozo
    Danmei Tian
    Xiyang Tang
    Yi Dai
    Xinsheng Yao
    Jinshan Tang
    Youwei Zhang
    Acta Pharmaceutica Sinica B, 2022, 12 (03) : 1339 - 1350
  • [3] Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR
    Wang, Fangfang
    Jin, Sora
    Pozo, Franklin Mayca
    Tian, Danmei
    Tang, Xiyang
    Dai, Yi
    Yao, Xinsheng
    Tang, Jinshan
    Zhang, Youwei
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (03) : 1339 - 1350
  • [4] ATM signaling and genornic stability in response to DNA damage
    Lavin, MF
    Birrell, G
    Chen, P
    Kozlov, S
    Scott, S
    Gueven, N
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005, 569 (1-2) : 123 - 132
  • [5] ATM acts downstream of ATR in the DNA damage response signaling of bystander cells
    Burdak-Rothkamm, Susanne
    Rothkamm, Kai
    Prise, Kevin M.
    CANCER RESEARCH, 2008, 68 (17) : 7059 - 7065
  • [6] Activation of ATM/ATR signaling in human embryonic stem cells after DNA damage
    Suvorova I.I.
    Kozhukharova I.V.
    Nikolsky N.N.
    Pospelov V.A.
    Cell and Tissue Biology, 2014, 8 (2) : 122 - 132
  • [7] ATM and ATR are not required for DNA damage-dependent accumulation of Chk1 at the centrosome.
    Loeffler, H
    Bochtler, T
    Ho, AD
    Jeggo, PA
    Bartek, J
    Kraemer, A
    BLOOD, 2005, 106 (11) : 152B - 152B
  • [8] CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage
    Vadnais, Charles
    Davoudi, Sayeh
    Afshin, Mojdeh
    Harada, Ryoko
    Dudley, Rachel
    Clermont, Pier-Luc
    Drobetsky, Elliot
    Nepveu, Alain
    NUCLEIC ACIDS RESEARCH, 2012, 40 (10) : 4483 - 4495
  • [9] The ATM-Chk2 and ATR-Chk1 Pathways in DNA Damage Signaling and Cancer
    Smith, Joanne
    Tho, Lye Mun
    Xu, Naihan
    Gillespie, David A.
    ADVANCES IN CANCER RESEARCH, VOL 108, 2010, 108 : 73 - 112
  • [10] A chemical genetic screen identifies novel ATM/ATR pathway inhibitors that sensitize p53-deficient cells to DNA-damaging agents without affecting ATR kinase catalytic activity
    Kawasumi, Masaoki
    Bradner, James E.
    Tolliday, Nicola
    Thibodeau, Renee
    Sloan, Heather
    Brummond, Kay M.
    Nghiem, Paul
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05)